Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Giant rhyolite lava dome formation after 7.3 ka supereruption at Kikai caldera, SW Japan.

Tatsumi Y, Suzuki-Kamata K, Matsuno T, Ichihara H, Seama N, Kiyosugi K, Nakaoka R, Nakahigashi K, Takizawa H, Hayashi K, Chiba T, Shimizu S, Sano M, Iwamaru H, Morozumi H, Sugioka H, Yamamoto Y.

Sci Rep. 2018 Feb 9;8(1):2753. doi: 10.1038/s41598-018-21066-w.

2.
3.

Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.

Matsuda Y, Sugiura K, Hashimoto T, Ueda A, Konno Y, Tatsumi Y.

PLoS One. 2016 Jul 21;11(7):e0159661. doi: 10.1371/journal.pone.0159661. eCollection 2016.

4.

Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success.

Pollak RA, Siu WJJ, Tatsumi Y, Pillai R.

J Fungi (Basel). 2015 Jul 3;1(2):107-114. doi: 10.3390/jof1020107. Review.

5.

[Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug].

Tatsumi Y.

Nihon Yakurigaku Zasshi. 2015 May;145(5):250-8. doi: 10.1254/fpj.145.250. Review. Japanese. No abstract available.

PMID:
25958913
6.

Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.

Sakamoto M, Sugimoto N, Kawabata H, Yamakawa E, Kodera N, Pillai R, Tatsumi Y.

J Drugs Dermatol. 2014 Nov;13(11):1388-92.

PMID:
25607707
7.

Cause and risk of catastrophic eruptions in the Japanese Archipelago.

Tatsumi Y, Suzuki-Kamata K.

Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(9):347-52.

8.

In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.

Iwata A, Watanabe Y, Kumagai N, Katafuchi-Nagashima M, Sugiura K, Pillai R, Tatsumi Y.

Antimicrob Agents Chemother. 2014 Aug;58(8):4920-2. doi: 10.1128/AAC.02703-13. Epub 2014 May 27.

9.

The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.

Sugiura K, Sugimoto N, Hosaka S, Katafuchi-Nagashima M, Arakawa Y, Tatsumi Y, Jo Siu W, Pillai R.

Antimicrob Agents Chemother. 2014 Jul;58(7):3837-42. doi: 10.1128/AAC.00111-14. Epub 2014 Apr 21.

10.

Mechanism of action of efinaconazole, a novel triazole antifungal agent.

Tatsumi Y, Nagashima M, Shibanushi T, Iwata A, Kangawa Y, Inui F, Siu WJ, Pillai R, Nishiyama Y.

Antimicrob Agents Chemother. 2013 May;57(5):2405-9. doi: 10.1128/AAC.02063-12. Epub 2013 Mar 4.

11.

Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.

Jo Siu WJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, Fothergill A.

Antimicrob Agents Chemother. 2013 Apr;57(4):1610-6. doi: 10.1128/AAC.02056-12. Epub 2013 Jan 14.

12.

Introducing site-specific glycosylation using protein engineering techniques reduces the immunogenicity of ╬▓-lactoglobulin.

Tatsumi Y, Sasahara Y, Kohyama N, Ayano S, Endo M, Yoshida T, Yamada K, Totsuka M, Hattori M.

Biosci Biotechnol Biochem. 2012;76(3):478-85.

13.

[Characteristic evaluation and clinical usefulness of dose area product meter at radiography].

Nakamae M, Tatsumi Y, Morioka S, Masuda S, Kitanaka Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2011;67(11):1448-53. Japanese.

14.

The structure of iron in Earth's inner core.

Tateno S, Hirose K, Ohishi Y, Tatsumi Y.

Science. 2010 Oct 15;330(6002):359-61. doi: 10.1126/science.1194662.

15.

F2928-1 and -2, new antifungal antibiotics from Cladobotryum sp.

Kanai Y, Tatsumi Y, Tokiwa T, Watanabe Y, Fujimaki T, Ishiyama D, Okuda T.

J Antibiot (Tokyo). 2005 Aug;58(8):507-13.

PMID:
16266122
16.

Supplemental Content

Loading ...
Support Center